“…The addition of growth factors and osteoclast inhibitors has a positive effect on the quality of newly formed bone tissue [ 26 , 27 , 28 , 29 , 30 ], whereas the addition of anticoagulants may reduce the risk of clot formation and improve the blood compatibility of the biomaterials without affecting cell proliferation [ 31 ]. A number of factors influence the kinetics of the drug release, with the selection of an appropriate coating material and coating deposition technique (e.g., 3D printing, electrospinning [ 32 ], electrophoretic deposition [ 30 ], dip coating [ 33 ], drop casting [ 34 ], sol-gel deposition [ 35 ], biomimetic deposition [ 36 ], layer-by-layer deposition (LbL) [ 15 ], anodization [ 37 ], etc.) being particularly important, as they dictate the final shape of the drug delivery system, thus allowing a controlled and prolonged release for up to several months [ 38 , 39 , 40 , 41 , 42 ].…”